Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2011 May 9:567–578. [Article in German] doi: 10.1007/978-3-642-16929-8_44

Hepatobiliäre Funktionsstörungen und Leberversagen

Rudolf E Stauber 6, Peter Fickert 7, Michael Trauner 8
Editors: Hilmar Burchardi1, Reinhard Larsen2, Gernot Marx3, Elke Muhl4, Jürgen Schölmerich5
PMCID: PMC7122907

Zusammenfassung

Als »sepsisinduzierte Cholestase« bezeichnet man das Auftreten einer konjugierten Hyperbilirubinämie als Folge einer extrahepatischen bakteriellen Infektion ohne direkte Invasion der Leber durch Erreger.

Literatur

  • 1.Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136(7):2159–2168. doi: 10.1053/j.gastro.2009.02.050. [DOI] [PubMed] [Google Scholar]
  • 2.Als-Nielsen B, Gluud LL, Gluud C. Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ. 2004;328(7447):1046. doi: 10.1136/bmj.38048.506134.EE. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Ketevan P, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129:512–521. doi: 10.1053/j.gastro.2005.05.006. [DOI] [PubMed] [Google Scholar]
  • 4.Bernal W, Donaldson N, Wyncoll D, Wendon J. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet. 2002;359(9306):558–563. doi: 10.1016/S0140-6736(02)07743-7. [DOI] [PubMed] [Google Scholar]
  • 5.Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johann M, Azoulay D, Ducot B, Chiche L. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg. 1995;222(2):109–119. doi: 10.1097/00000658-199508000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.British Committee for Standards in Haematology, Blood Transfusion Task Force (Chairman P. Kelsey) Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122:10–23. [Google Scholar]
  • 7.Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contribution factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132(7):525–532. doi: 10.7326/0003-4819-132-7-200004040-00003. [DOI] [PubMed] [Google Scholar]
  • 8.Chung C, Buchman AL. Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction. Clin Liver Dis. 2002;6:1067–1084. doi: 10.1016/S1089-3261(02)00057-0. [DOI] [PubMed] [Google Scholar]
  • 9.Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29(3):648–653. doi: 10.1002/hep.510290309. [DOI] [PubMed] [Google Scholar]
  • 10.Cordoba J, Lopez-Hellin J, Planas M, Sabin P, Sanpedro F, Castro F, Esteban R, Guardia J. Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol. 2004;41(1):38–43. doi: 10.1016/j.jhep.2004.03.023. [DOI] [PubMed] [Google Scholar]
  • 11.Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35(3):716–721. doi: 10.1053/jhep.2002.31250. [DOI] [PubMed] [Google Scholar]
  • 12.Fuchs S, Bogomilski-Yahalom V, Platiel O, Ackerman Z. Ischemic hepatitis: clinical and laboratory observations of 34 patients. J Clin Gastroenterol. 1998;26(3):183–186. doi: 10.1097/00004836-199804000-00007. [DOI] [PubMed] [Google Scholar]
  • 13.Gibson PR, Dudley FJ. Ischemic hepatitis clinical features, dignosis and prognosis. Aust NZ I Med. 1984;14:822–825. doi: 10.1111/j.1445-5994.1984.tb03780.x. [DOI] [PubMed] [Google Scholar]
  • 14.Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990;335(8705):1572–1573. doi: 10.1016/0140-6736(90)91388-Q. [DOI] [PubMed] [Google Scholar]
  • 15.Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23(2):71–77. doi: 10.1034/j.1600-0676.2003.00813.x. [DOI] [PubMed] [Google Scholar]
  • 16.Hassanein TI, Tofteng F, Brown RS, Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology. 2007;46(6):1853–1862. doi: 10.1002/hep.21930. [DOI] [PubMed] [Google Scholar]
  • 17.Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology. 2002;36(4 Pt 1):949–958. doi: 10.1053/jhep.2002.36130. [DOI] [PubMed] [Google Scholar]
  • 18.Henrion J, Schapira M, Luwaert R, Colin L, Delannoy A, Heller F. Hypoxic hepatitis. Clinical and hemodynamic study in 142 consecutive cases. Medicine. 2003;82(6):392–406. doi: 10.1097/01.md.0000101573.54295.bd. [DOI] [PubMed] [Google Scholar]
  • 19.Jalan R, Damink SW, Deutz NE, Lee A, Hayes PC. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet. 1999;354(9185):1164–1168. doi: 10.1016/S0140-6736(98)12440-6. [DOI] [PubMed] [Google Scholar]
  • 20.Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif. 2002;20(3):252–261. doi: 10.1159/000047017. [DOI] [PubMed] [Google Scholar]
  • 21.Jalan R, Sen S, Williams R. Prospects for extracorporeal liver support. Gut. 2004;53(6):890–898. doi: 10.1136/gut.2003.024919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Johnson RD, O´Connor ml, Kerr RM. Extreme serum elevations of aspartate aminotransferase. Am J Gastroenterol. 1995;90(8):1244–1245. [PubMed] [Google Scholar]
  • 23.Kircheis G, Nilius R, Held C, Berndt H, Buchner M, Gortelmeyer R, Hendricks R, Kruger B, Kuklinski B, Meister H, Otto HJ, Rink C, Rosch W, Stauch S. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebocontrolled, double-blind study. Hepatology. 1997;25(6):1351–1360. doi: 10.1002/hep.510250609. [DOI] [PubMed] [Google Scholar]
  • 24.Austrian Epidemiologic Study on Intensive Care, ASDI Study Group Incidence and prognosis of early hepatic dysfunction in critically ill patients – a prospective multicenter study. Crit Care Med. 2007;354:1099–1104. doi: 10.1097/01.CCM.0000259462.97164.A0. [DOI] [PubMed] [Google Scholar]
  • 25.Krisper P, Haditsch B, Stauber R, Jung A, Stadlbauer V, Trauner M, Holzer H, Schneditz D. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J Hepatol. 2005;43:451–457. doi: 10.1016/j.jhep.2005.02.038. [DOI] [PubMed] [Google Scholar]
  • 26.Acute Liver Failure Study Group Intravenous N-acetylcysteine improves transplant- free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856–864. doi: 10.1053/j.gastro.2009.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Lefkowitch J. Bile ductular cholestasis: an ominous histopathologic sign related to sepsis and »cholangitis lenta«. Human Pathol. 1982;13:19–24. doi: 10.1016/S0046-8177(82)80134-2. [DOI] [PubMed] [Google Scholar]
  • 28.Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, Sigal S, Sheikh MY, Beavers K, Frederick T, Teperman L, Hillebrand D, Huang S, Merchant K, Shaw A, Bortey E, Forbes WP. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362:1071–1081. doi: 10.1056/NEJMoa0907893. [DOI] [PubMed] [Google Scholar]
  • 29.Mariat G, Mahul P, Prevot M, De Filippis J, Cuilleron M, Dubois F, et al. Contribution of ultrasonography and cholescintigraphy to the diagnosis of acute acalculous cholecystitis in intensive care unit patients. Intensive Care Med. 2000;26:1658–1663. doi: 10.1007/s001340000684. [DOI] [PubMed] [Google Scholar]
  • 30.McChesney JA, Northup PG, Bickston SJ. Acute acalculous cholecystitis associated with systemic sepsis and visceral arterial hypoperfusion: a case series and review of pathophysiology. Dig Dis Sci. 2003;48(10):1960–1970. doi: 10.1023/A:1026118320460. [DOI] [PubMed] [Google Scholar]
  • 31.Meier Y, Cavallaro M, Roos M, Pauli-Magnus C, Folkers G, Meier PJ, et al. Incidence of drug-induced lliver injury in medical inpatients. Eur J Clin Pharmacol. 2005;61(2):135–145. doi: 10.1007/s00228-004-0888-z. [DOI] [PubMed] [Google Scholar]
  • 32.Mitzner S, Klammt S, Stange J, Schmidt R. Albumin regeneration in liver support –comparison of different methods. Ther Apher Dial. 2006;10(2):108–117. doi: 10.1111/j.1744-9987.2006.00351.x. [DOI] [PubMed] [Google Scholar]
  • 33.Moseley RH. Sepsis and cholestasis. Clin Liver Dis. 2004;8:83. doi: 10.1016/S1089-3261(03)00134-X. [DOI] [PubMed] [Google Scholar]
  • 34.O´Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–445. doi: 10.1016/0016-5085(89)90081-4. [DOI] [PubMed] [Google Scholar]
  • 35.O´Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993;342(8866):273–275. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  • 36.U.S. Acute Liver Failure Study Group Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137(12):947–954. doi: 10.7326/0003-4819-137-12-200212170-00007. [DOI] [PubMed] [Google Scholar]
  • 37.Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–1197. doi: 10.1002/hep.20703. [DOI] [PubMed] [Google Scholar]
  • 38.Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis. 1996;16(4):389–402. doi: 10.1055/s-2007-1007252. [DOI] [PubMed] [Google Scholar]
  • 39.Roslyn JJ, Pitt HA, Mann LL, Ament ME, Den Besten L. Gallbladder disease in patients on long-term parenteral nutrition. Gastroenterology. 1983;84:148–154. [PubMed] [Google Scholar]
  • 40.Ruemmele P, Hofstaedter F, Gelbmann CM; Medscape (2009) Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 6 (5): 287–295 [DOI] [PubMed]
  • 41.Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–1318. doi: 10.1136/gut.2006.107789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Seeto RK, Fenn B, Rockey DC. Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med. 2000;109(2):109–113. doi: 10.1016/S0002-9343(00)00461-7. [DOI] [PubMed] [Google Scholar]
  • 43.Sharma P, Kumar A, Shrama BC, Sarin SK. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol. 2008;103(7):1689–1697. doi: 10.1111/j.1572-0241.2008.01828.x. [DOI] [PubMed] [Google Scholar]
  • 44.Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology. 2009;137(3):885–891. doi: 10.1053/j.gastro.2009.05.056. [DOI] [PubMed] [Google Scholar]
  • 45.Stravitz RT, Larsen FS. Therapeutic hypothermia for acute liver failure. Crit Care Med. 2009;37(7 Suppl):S258–S264. doi: 10.1097/CCM.0b013e3181aa5fb8. [DOI] [PubMed] [Google Scholar]
  • 46.Strazzabosco M, Fabris L, Spirli C. Pathophysiology of cholangiopathies. J Clin Gastroenterol. 2005;39(Suppl 2):90–102. doi: 10.1097/01.mcg.0000155549.29643.ad. [DOI] [PubMed] [Google Scholar]
  • 47.Towbridge RL, Rutkowski NK, Shojania KG. Does the patient have acute cholecystitis? JAMA. 2003;289(1):80–86. doi: 10.1001/jama.289.1.80. [DOI] [PubMed] [Google Scholar]
  • 48.Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol. 1999;14(10):946–959. doi: 10.1046/j.1440-1746.1999.01982.x. [DOI] [PubMed] [Google Scholar]

Articles from Die Intensivmedizin are provided here courtesy of Nature Publishing Group

RESOURCES